Rallybio Corp
Biotechnology
Healthcare
RLYB
40.36 M shares
NASDAQ US
traded
02 Jan 2024
listed
no
open
2.37
52 week high
8.89
high
2.46
52 week low
1.91
low
2.33
growth
-61.10 %
previous Close
2.39
P/E ratio
market cap
205 M
div yield
0
usd
Sep 2023
qoq
revenue
0.00 %
net incoming
0.00 %
eps
0.00 %
0.00 %
eps surprise
100.00 %
net profit margin
0.00 %
0.00 %
operating incoming
0.00 %
net change in cash
0.00 %
cash on hand
0.00 %
cost of revenue
0.00 %
top top